BXP — Beximco Pharmaceuticals Share News
0.000.00%
- £171.75m
- £237.96m
- BDT39.27bn
- 96
- 97
- 67
- 99
REG - Beximco Pharmaceut - Stock Dividend Issued
AnnouncementREG - Beximco Pharmaceut - Confirmation of Board Changes
AnnouncementREG - Beximco Pharmaceut - AGM Statement
AnnouncementREG - Beximco Pharmaceut - Board Changes
AnnouncementREG - Beximco Pharmaceut - Notice of AGM
AnnouncementREG - Beximco Pharmaceut - Results for First Quarter Ended 30 September 2020
AnnouncementREG - Beximco Pharmaceut - Results for the year ended 30 June 2020
AnnouncementREG - Beximco Pharmaceut - Second Price Monitoring Extn
AnnouncementREG - Beximco Pharmaceut - Price Monitoring Extension
AnnouncementREG - Beximco Pharmaceut - MOU with SII and GOB for COVID-19 vaccine
AnnouncementREG - Beximco Pharmaceut - Notification of Preliminary Results and AGM
AnnouncementREG - Beximco Pharmaceut - Beximco Pharma receives eighth FDA approval
AnnouncementREG - Beximco Pharmaceut - Second Price Monitoring Extn
AnnouncementREG - Beximco Pharmaceut - Price Monitoring Extension
AnnouncementREG - Beximco Pharmaceut - Beximco and SII to cooperate on a COVID-19 vaccine
AnnouncementREG - Beximco Pharmaceut - Board Change
AnnouncementREG - Beximco Pharmaceut - Q3 Financial Results and Business Update
AnnouncementREG - Beximco Pharmaceut - World’s first generic remdesivir for COVID-19
AnnouncementREG - Beximco Pharmaceut - COVID-19 Update
Announcement